FIGS, Inc. Stock: price and insider trades · United States · SEC (Form 4)Track the FIGS, Inc. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, FIGS, Inc. has published 149 public disclosures. Market capitalisation: €1.8bn. The latest transaction was disclosed on 7 August 2026 (Retenue fiscale). Among the most active insiders: Hasson Heather L.. All data is free.
Analyst consensus: bullish or bearish? Analysts rate FIGS, Inc. Buy (bullish), based on 8 analysts. Average price target: US$17.63.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,751 of 29,062 companies
FCF yld 2.1%
Earn yld 1.3%
EV/EBITDA 55.6x
ROE 15%
Gross mgn 67%
Net mgn 5.4%
Debt/EBITDA 1.3x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 August 2026
All Executives149 Thresholds0 Prospectus0 Other0
Declarations 149 total
● Chief Financial Officer · Executives · 5 Aug 2026
21,962 shares @ US$10.92 Class A Common Stock SEC:0001628280-26-054839:0
● Executive Chairman · Executives · 5 Aug 2026
30,142 shares @ US$10.92 Class A Common Stock SEC:0001628280-26-054847:0
● Executive Chairman · Executives · 1 Jul 2026
6,813 shares @ US$10.05 0.0041% mcap 0.3% of flow Class A Common Stock SEC:0001628280-26-047413:0
● Chief Executive Officer · Executives · 1 Jul 2026
61,556 shares @ US$10.05 0.037% mcap 2.8% of flow Class A Common Stock SEC:0001628280-26-047417:0
● Chief Financial Officer · Executives · 1 Jul 2026
22,197 shares @ US$10.05 0.013% mcap 6.9% of flow Class A Common Stock SEC:0001628280-26-047419:0
◆ Director · Executives · 3 Jun 2026
15,456 shares 0Class A Common Stock SEC:0001628280-26-040592:0
▼ Executive Chairman · Executives · 4 May 2026
32,385 shares @ US$14.3339 0.021% mcap 3.0% of flow Class A Common Stock SEC:0001628280-26-031586:0
▼ Chief Financial Officer · Executives · 4 May 2026
23,597 shares @ US$14.3339 0.015% mcap 10.9% of flow Class A Common Stock SEC:0001628280-26-031588:0
▼ Chief Executive Officer · Executives · 2 Apr 2026
62,335 shares @ US$14.4389 0.041% mcap 5.5% of flow Class A Common Stock SEC:0001628280-26-023974:0
▼ Chief Financial Officer · Executives · 2 Apr 2026
10,872 shares @ US$14.4389 0.0072% mcap 5.1% of flow Class A Common Stock SEC:0001628280-26-023976:0
◆ Chief Financial Officer · Executives · 3 Mar 2026
342,760 shares 0Class A Common Stock SEC:0001628280-26-015287:0
◆ Executive Chairman · Executives · 3 Mar 2026
214,225 shares 0Class A Common Stock SEC:0001628280-26-015261:0
◇ Executive Chair · Executives · 2 Mar 2026
313,336 shares @ US$0.85 1.7% of flow Class A Common Stock SEC:0001628280-26-014044:0
▼ Executive Chair · Executives · 5 Feb 2026
22,874 shares @ US$10.56 0.011% mcap 1.5% of flow Class A Common Stock SEC:0001628280-26-006583:0
▼ Chief Financial Officer · Executives · 5 Feb 2026
22,690 shares @ US$10.56 0.011% mcap 7.6% of flow Class A Common Stock SEC:0001628280-26-006597:0
▼ Chief Financial Officer · Executives · 7 Jan 2026
10,515 shares @ US$11.5004 0.0055% mcap 3.9% of flow Class A Common Stock SEC:0001628280-26-001435:0
▼ Chief Executive Officer · Executives · 6 Jan 2026
49,734 shares @ US$11.3789 0.026% mcap 3.4% of flow Class A Common Stock SEC:0001628280-26-001432:0
▼ Chief Financial Officer · Executives · 4 Nov 2025
22,745 shares @ US$7.3869 8.7% of flow Class A Common Stock SEC:0001628280-25-050355:0
▼ Executive Chair · Executives · 4 Nov 2025
23,356 shares @ US$7.3869 1.1% of flow Class A Common Stock SEC:0001628280-25-050351:0
▼ Chief Financial Officer · Executives · 3 Oct 2025
9,968 shares @ US$7.36 0.0033% mcap 2.4% of flow Class A Common Stock SEC:0001628280-25-044387:0
▼ Chief Executive Officer · Executives · 2 Oct 2025
62,213 shares @ US$6.8809 0.019% mcap 2.6% of flow Class A Common Stock SEC:0001628280-25-044385:0
▼ Chief Executive Officer · Executives · 13 Aug 2025
65,866 shares @ US$6.88 0.021% mcap 2.7% of flow Class A Common Stock SEC:0001820448-25-000006:0
◆ Executive Chair · Executives · 12 Aug 2025
947,868 shares 0Class A Common Stock SEC:0001843821-25-000004:0
▼ Chief Financial Officer · Executives · 4 Aug 2025
99,834 shares @ US$6.19 0.028% mcap 20.1% of flow Class A Common Stock SEC:0001628280-25-038400:0
◆ Director · Executives · 4 Jun 2025
29,412 shares 0Class A Common Stock SEC:0001628280-25-030016:0
25 of 149 declarations
Load more (124 remaining) 关于 FIGS, Inc. FIGS, Inc. 是一家总部位于加利福尼亚州圣莫尼卡的美国公司,在纽约证券交易所上市,股票代码为 FIGS。该公司成立于 2013 年,已建立了一个直接面向消费者的医疗服装品牌,专注于医疗制服和医疗专业人员的相关产品。从股票研究的角度来看,FIGS 在一个历史上分散且品牌化不足的类别中脱颖而出,成为一个高端品牌,它试图将手术服从一种商品产品提升为一种设计主导、技术差异化的产品。
该公司的业务围绕两条主要产品线展开。核心类别是手术服:旨在满足临床医生功能需求,同时强调舒适性、耐用性和风格的医用工作服。第二个类别是非手术服,包括外套、内搭手术服、鞋类、压力袜、实验服、休闲服和其他服装。FIGS 将这些产品定位为一个集成系统,为医疗专业人员在工作和休息期间提供服务。
FIGS 主要通过其数字直接面向消费者平台进行销售,包括其网站和移动应用程序,这使公司能够直接获取消费者需求、品牌参与数据和商品销售洞察。它还运营实体“社区中心”,这些中心作为品牌体验而非传统的批发零售门店。此外,该公司还建立了 TEAMS,这是一个面向医院、诊所和其他医疗机构的 B2B 渠道。
在竞争方面,FIGS 在高端医疗服装领域占据了强势地位,这得益于其知名品牌、忠实的客户群以及将性能特点与生活方式定位相结合的产品策略。然而,市场竞争依然激烈,面临来自专业服装厂商和更广泛制服品牌的压力。FIGS 的差异化优势在于其品牌资产、直接客户关系、内部产品开发以及数据驱动的库存和补货模式。该公司的备案文件显示,其拥有数百万活跃客户,业务仍高度集中在美国,尽管它也通过 FIGS Canada, Inc. 运营。
近期亮点对投资者很重要。2026 年初,FIGS 公布了 2025 财年全年业绩,并表示第四季度净收入同比增长显著,盈利能力指标也有所改善。管理层还指出,2026 财年的目标是实现两位数低增长的收入和利润率扩张。对于讲法语的投资者来说,FIGS 最好被视为一个专业消费医疗品牌,其业务受医疗就业趋势、品牌忠诚度以及增长、盈利能力和商品销售纪律执行情况的影响。